MétaCan
Menu
Back to cohort
Record W2156415438 · doi:10.4021/jocmr1583w

Empirical Use of Dopaminergic Agents for Restless Legs Syndrome Could be Associated With a Risk of Iatrogenic Parkinson’s Disease

2013· article· en· W2156415438 on OpenAlexvenueno aff
Sugita Sugita

Bibliographic record

VenueJournal of Clinical Medicine Research · 2013
Typearticle
Languageen
FieldMedicine
TopicRestless Legs Syndrome Research
Canadian institutionsnot available
Fundersnot available
KeywordsDopaminergicMedicineRestless legs syndromeDopamineDopamine agonistAgonistPopulationNeuroscienceDiseaseDopamine receptorAnesthesiaInternal medicinePharmacologyReceptorPsychology

Abstract

fetched live from OpenAlex

Several drugs acting on the central nervous system (CNS) have been indicated for the treatment of restless legs syndrome (RLS), particularly pramipexol, which is a dopamine D2 receptor agonist [1, 2]. However, there is no significant evidence for a decrease of dopamine derivatives in patients with RLS, and association with Parkinson’s disease is not common. In fact, the use of dopaminergic agents for RLS has been merely empirical up to now. It can be easily envisaged that a continuous dopamine load in normal persons might lead to depletion of intrinsic dopamine production. Because the prevalence of RLS is surprisingly high, up to 10% of the general population might be considered candidates for dopaminergic therapy. The original report of RLS by Ekbom in 1945 emphasized the usefulness of vasodilative agents [3, 4]. On the other hand, a dopamine D2 receptor agonist has been clearly mentioned as a strong vasodilator even in a widely used textbook of pharmacology [5]. Other CNS drugs recommended for RLS, such as benzodiazepines and opioids, also have vasodilative effects on the peripheral circulation in addition to effects on the CNS. Recently, I have been proposed a new hypothesis suggesting that stimulation of the autonomic nervous system distributed to vessels in the lower legs could be the origin of the unpleasant sensations in RLS [6, 7]. Fifteen hours of exposure to gravity during the daytime, compressing the vessels in the lower legs, is required for occurrence of the unpleasant sensations. An abrupt change of blood flow in the legs due to lying down at night may cause abnormal tension of blood vessels, inducing unexpected excitement of the autonomic nervous system, especially in individuals with impaired vessel elasticity and distensibility. This provides a quite reasonable explanation for why the sensations occur upon lying down and disappear when walking. Circadian rhythm seems unlikely to account for it. As well as CNS drugs, several drugs that act potent vasodilators would be worth trying for treatment of RLS. For example, it is often experienced that even vitamins E and B12 have shown some effectiveness for dermatology patients complaining night itching in the feet. Because of its primary action on the CNS, the use of dopamine D2 receptor agonist might be limited for severe cases that are deeply affecting the quality of life. In order to prevent an iatrogenic Parkinson’s disease, long-term use should be limited for patients who have associated Parkinson’s disease and it must be worth trying the combined use of a daily dose of 300 mg oral tocopherol acetate (vitamin E) which is supporting the peripheral blood circulation, and a daily dose of 750 μg oral mecobalamin (vitamin B12) which is preventing excessive excitement of the autonomic nerve system.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.017
metaresearch head score (Gemma)0.083
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch, Research integrity
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.066
Threshold uncertainty score0.999

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0170.083
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0030.001
Bibliometrics0.0010.002
Science and technology studies0.0000.002
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.003
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.479
GPT teacher head0.554
Teacher spread0.074 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2013
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Medicine ResearchSame topicRestless Legs Syndrome ResearchFrench-language works237,207